Concepts (282)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electroencephalography | 39 | 2024 | 772 | 2.840 |
Why?
|
| Brain Mapping | 22 | 2024 | 580 | 2.040 |
Why?
|
| Epilepsy | 18 | 2024 | 431 | 1.640 |
Why?
|
| Visual Prosthesis | 3 | 2023 | 5 | 1.600 |
Why?
|
| Cerebral Cortex | 12 | 2020 | 593 | 1.590 |
Why?
|
| Visual Cortex | 8 | 2022 | 256 | 1.570 |
Why?
|
| Epilepsy, Temporal Lobe | 9 | 2022 | 133 | 1.140 |
Why?
|
| Electrodes, Implanted | 12 | 2024 | 197 | 1.070 |
Why?
|
| Evoked Potentials, Visual | 13 | 2019 | 88 | 0.920 |
Why?
|
| Language | 2 | 2020 | 158 | 0.880 |
Why?
|
| Nerve Net | 4 | 2020 | 396 | 0.830 |
Why?
|
| Brain | 18 | 2024 | 2355 | 0.820 |
Why?
|
| Electrocorticography | 6 | 2024 | 47 | 0.730 |
Why?
|
| Evoked Potentials, Somatosensory | 9 | 2010 | 34 | 0.620 |
Why?
|
| National Socialism | 1 | 2016 | 3 | 0.510 |
Why?
|
| Magnetic Resonance Imaging | 14 | 2020 | 3514 | 0.510 |
Why?
|
| Subdural Space | 3 | 2024 | 19 | 0.500 |
Why?
|
| Visual Perception | 9 | 2022 | 330 | 0.480 |
Why?
|
| Auditory Cortex | 3 | 2022 | 60 | 0.470 |
Why?
|
| Neurology | 1 | 2016 | 78 | 0.470 |
Why?
|
| Speech Perception | 2 | 2021 | 72 | 0.460 |
Why?
|
| Temporal Lobe | 5 | 2022 | 185 | 0.450 |
Why?
|
| Electric Stimulation | 6 | 2023 | 371 | 0.450 |
Why?
|
| Occipital Lobe | 4 | 2023 | 24 | 0.410 |
Why?
|
| Electrodes | 9 | 2024 | 89 | 0.400 |
Why?
|
| Phosphenes | 3 | 2021 | 5 | 0.400 |
Why?
|
| Humans | 77 | 2024 | 92331 | 0.360 |
Why?
|
| Pattern Recognition, Visual | 4 | 2003 | 159 | 0.350 |
Why?
|
| Auditory Perception | 4 | 2022 | 98 | 0.340 |
Why?
|
| Child | 18 | 2020 | 7309 | 0.340 |
Why?
|
| Adolescent | 19 | 2020 | 9495 | 0.320 |
Why?
|
| Speech | 2 | 2021 | 88 | 0.320 |
Why?
|
| Hippocampus | 4 | 2022 | 435 | 0.320 |
Why?
|
| Scalp | 6 | 2022 | 70 | 0.310 |
Why?
|
| Frontal Lobe | 2 | 2008 | 130 | 0.310 |
Why?
|
| Seizures | 5 | 2018 | 314 | 0.290 |
Why?
|
| Male | 44 | 2020 | 43922 | 0.280 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2007 | 334 | 0.280 |
Why?
|
| Adult | 34 | 2020 | 27540 | 0.280 |
Why?
|
| Drug Resistant Epilepsy | 2 | 2018 | 57 | 0.280 |
Why?
|
| Models, Animal | 3 | 2020 | 281 | 0.260 |
Why?
|
| Vision Disorders | 3 | 2021 | 73 | 0.260 |
Why?
|
| Female | 43 | 2020 | 47895 | 0.250 |
Why?
|
| Signal Processing, Computer-Assisted | 5 | 2010 | 203 | 0.240 |
Why?
|
| Evoked Potentials, Auditory | 2 | 2019 | 37 | 0.230 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2007 | 607 | 0.230 |
Why?
|
| Implants, Experimental | 1 | 2003 | 16 | 0.210 |
Why?
|
| United States Agency for Healthcare Research and Quality | 1 | 2003 | 6 | 0.210 |
Why?
|
| Prosopagnosia | 1 | 2003 | 1 | 0.210 |
Why?
|
| Dominance, Cerebral | 2 | 2000 | 67 | 0.210 |
Why?
|
| Blindness | 1 | 2003 | 39 | 0.210 |
Why?
|
| Imagination | 1 | 2003 | 44 | 0.210 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 3 | 1998 | 18 | 0.200 |
Why?
|
| Middle Aged | 22 | 2020 | 27043 | 0.200 |
Why?
|
| Sleep | 4 | 2022 | 462 | 0.200 |
Why?
|
| Memory Consolidation | 1 | 2022 | 15 | 0.200 |
Why?
|
| Monitoring, Intraoperative | 1 | 2003 | 109 | 0.200 |
Why?
|
| Young Adult | 7 | 2020 | 6629 | 0.190 |
Why?
|
| Face | 1 | 2003 | 114 | 0.190 |
Why?
|
| Parietal Lobe | 1 | 2003 | 119 | 0.190 |
Why?
|
| Stereotaxic Techniques | 2 | 2024 | 82 | 0.190 |
Why?
|
| Spinal Cord Injuries | 1 | 2023 | 83 | 0.190 |
Why?
|
| Space Perception | 1 | 2003 | 117 | 0.190 |
Why?
|
| Equipment Design | 2 | 2016 | 420 | 0.180 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2016 | 2685 | 0.180 |
Why?
|
| Health Personnel | 1 | 2003 | 223 | 0.170 |
Why?
|
| Reflex, Righting | 1 | 2020 | 2 | 0.170 |
Why?
|
| Somatosensory Cortex | 3 | 2000 | 153 | 0.170 |
Why?
|
| Motor Activity | 3 | 2016 | 330 | 0.170 |
Why?
|
| Brain Damage, Chronic | 1 | 2000 | 26 | 0.170 |
Why?
|
| Electrophysiology | 5 | 2012 | 402 | 0.170 |
Why?
|
| Deep Brain Stimulation | 2 | 2015 | 83 | 0.170 |
Why?
|
| Models, Neurological | 7 | 2010 | 425 | 0.170 |
Why?
|
| Isoflurane | 1 | 2020 | 64 | 0.170 |
Why?
|
| Nerve Regeneration | 1 | 2000 | 37 | 0.170 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2016 | 1270 | 0.160 |
Why?
|
| Theta Rhythm | 1 | 2020 | 36 | 0.160 |
Why?
|
| Posture | 2 | 2017 | 123 | 0.160 |
Why?
|
| Acoustic Stimulation | 5 | 2022 | 129 | 0.160 |
Why?
|
| Movement | 2 | 2023 | 317 | 0.160 |
Why?
|
| Anesthetics, Inhalation | 1 | 2020 | 97 | 0.160 |
Why?
|
| Caffeine | 1 | 2020 | 84 | 0.160 |
Why?
|
| Time Factors | 9 | 2019 | 5430 | 0.160 |
Why?
|
| Algorithms | 7 | 2010 | 1960 | 0.160 |
Why?
|
| Motor Cortex | 3 | 2016 | 206 | 0.160 |
Why?
|
| Entropy | 2 | 2010 | 42 | 0.160 |
Why?
|
| Hand | 1 | 2000 | 145 | 0.150 |
Why?
|
| Brain Waves | 1 | 2019 | 32 | 0.150 |
Why?
|
| Functional Laterality | 8 | 2019 | 201 | 0.150 |
Why?
|
| Visual Acuity | 7 | 1997 | 222 | 0.150 |
Why?
|
| Implantable Neurostimulators | 1 | 2018 | 12 | 0.150 |
Why?
|
| Evoked Potentials | 10 | 2003 | 191 | 0.150 |
Why?
|
| Limbic Encephalitis | 1 | 2018 | 11 | 0.140 |
Why?
|
| Glutamate Decarboxylase | 1 | 2018 | 32 | 0.140 |
Why?
|
| Neuronal Plasticity | 1 | 2000 | 195 | 0.140 |
Why?
|
| Sclerosis | 1 | 2017 | 29 | 0.140 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 166 | 0.140 |
Why?
|
| Encephalitis | 1 | 2018 | 98 | 0.140 |
Why?
|
| Sensation | 1 | 1998 | 50 | 0.140 |
Why?
|
| Death, Sudden | 1 | 2017 | 40 | 0.140 |
Why?
|
| Microelectrodes | 3 | 2023 | 87 | 0.140 |
Why?
|
| Prone Position | 1 | 2017 | 60 | 0.130 |
Why?
|
| Otolithic Membrane | 1 | 1997 | 13 | 0.130 |
Why?
|
| Computer Simulation | 6 | 2010 | 1112 | 0.130 |
Why?
|
| Saccule and Utricle | 1 | 1997 | 19 | 0.130 |
Why?
|
| Cats | 1 | 1997 | 305 | 0.130 |
Why?
|
| Wireless Technology | 1 | 2016 | 21 | 0.130 |
Why?
|
| Brain Diseases | 1 | 1998 | 186 | 0.130 |
Why?
|
| Laser Therapy | 1 | 2017 | 151 | 0.120 |
Why?
|
| Antibodies | 1 | 2018 | 351 | 0.120 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 2015 | 20 | 0.120 |
Why?
|
| Subthalamic Nucleus | 1 | 2015 | 23 | 0.120 |
Why?
|
| Video Recording | 2 | 2020 | 204 | 0.110 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 474 | 0.100 |
Why?
|
| Multiple Sclerosis | 2 | 1996 | 260 | 0.100 |
Why?
|
| Parkinson Disease | 1 | 2015 | 159 | 0.100 |
Why?
|
| Memory | 3 | 2004 | 223 | 0.100 |
Why?
|
| Hypogastric Plexus | 1 | 2012 | 4 | 0.100 |
Why?
|
| Urinary Retention | 1 | 2012 | 43 | 0.100 |
Why?
|
| Replantation | 1 | 2012 | 36 | 0.100 |
Why?
|
| Software | 2 | 2007 | 676 | 0.100 |
Why?
|
| Ureter | 1 | 2012 | 96 | 0.090 |
Why?
|
| Visual Pathways | 2 | 2003 | 153 | 0.090 |
Why?
|
| Neurons | 1 | 1999 | 1596 | 0.090 |
Why?
|
| Reaction Time | 7 | 1992 | 315 | 0.090 |
Why?
|
| Macaca | 2 | 2016 | 89 | 0.080 |
Why?
|
| Quadriplegia | 1 | 1989 | 27 | 0.080 |
Why?
|
| Photic Stimulation | 4 | 2019 | 505 | 0.080 |
Why?
|
| Skull | 3 | 2010 | 260 | 0.080 |
Why?
|
| Robotics | 1 | 2012 | 268 | 0.080 |
Why?
|
| Orientation | 2 | 1980 | 119 | 0.080 |
Why?
|
| Brain Stem | 1 | 1989 | 166 | 0.080 |
Why?
|
| Wakefulness | 2 | 2020 | 136 | 0.070 |
Why?
|
| Language Tests | 1 | 2008 | 37 | 0.070 |
Why?
|
| Animals | 9 | 2023 | 28060 | 0.070 |
Why?
|
| Anesthesia, General | 2 | 2020 | 119 | 0.070 |
Why?
|
| Oscillometry | 1 | 2007 | 25 | 0.070 |
Why?
|
| Visual Fields | 4 | 2004 | 99 | 0.070 |
Why?
|
| Spectrum Analysis | 1 | 2007 | 118 | 0.070 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2006 | 7 | 0.060 |
Why?
|
| Electromyography | 2 | 2017 | 191 | 0.060 |
Why?
|
| Holography | 1 | 2006 | 5 | 0.060 |
Why?
|
| Cell Physiological Phenomena | 1 | 2006 | 25 | 0.060 |
Why?
|
| Laparoscopy | 1 | 2012 | 767 | 0.060 |
Why?
|
| ROC Curve | 1 | 2008 | 786 | 0.060 |
Why?
|
| Vision Tests | 2 | 1983 | 20 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 2009 | 0.060 |
Why?
|
| Age Factors | 5 | 1998 | 1904 | 0.060 |
Why?
|
| Treatment Outcome | 5 | 2018 | 8730 | 0.060 |
Why?
|
| Communication | 1 | 2008 | 462 | 0.060 |
Why?
|
| Brain Neoplasms | 3 | 1999 | 807 | 0.050 |
Why?
|
| Child, Preschool | 4 | 2012 | 3806 | 0.050 |
Why?
|
| Epilepsy, Absence | 1 | 2003 | 10 | 0.050 |
Why?
|
| Credentialing | 1 | 2003 | 14 | 0.050 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 102 | 0.050 |
Why?
|
| Ocular Hypertension | 1 | 1983 | 8 | 0.050 |
Why?
|
| Size Perception | 2 | 1980 | 6 | 0.050 |
Why?
|
| Models, Biological | 2 | 2006 | 1785 | 0.050 |
Why?
|
| Eye Diseases | 1 | 1983 | 60 | 0.050 |
Why?
|
| Aged | 9 | 2017 | 19951 | 0.050 |
Why?
|
| Hemiplegia | 2 | 2000 | 15 | 0.050 |
Why?
|
| Glaucoma | 1 | 1983 | 35 | 0.050 |
Why?
|
| Spatial Memory | 1 | 2022 | 27 | 0.050 |
Why?
|
| Sound | 1 | 2022 | 25 | 0.050 |
Why?
|
| Patient Care | 1 | 2003 | 102 | 0.050 |
Why?
|
| Spine | 1 | 2023 | 132 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2023 | 244 | 0.050 |
Why?
|
| Swine | 1 | 2023 | 607 | 0.050 |
Why?
|
| Infant | 4 | 2000 | 3206 | 0.040 |
Why?
|
| Neuropsychological Tests | 3 | 2017 | 524 | 0.040 |
Why?
|
| Mental Recall | 1 | 2022 | 166 | 0.040 |
Why?
|
| Respiratory Rate | 1 | 2020 | 22 | 0.040 |
Why?
|
| Anesthesia Recovery Period | 1 | 2020 | 55 | 0.040 |
Why?
|
| Hypoglycemia | 2 | 1992 | 110 | 0.040 |
Why?
|
| Afferent Pathways | 1 | 2000 | 76 | 0.040 |
Why?
|
| Neurologic Examination | 1 | 2000 | 124 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 391 | 0.040 |
Why?
|
| Aphasia | 1 | 1999 | 15 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2003 | 2793 | 0.040 |
Why?
|
| Heart Rate | 2 | 2020 | 502 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2012 | 800 | 0.040 |
Why?
|
| Hearing Disorders | 1 | 1998 | 8 | 0.040 |
Why?
|
| Auditory Threshold | 1 | 1998 | 15 | 0.040 |
Why?
|
| Carboxy-Lyases | 1 | 2018 | 22 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 1998 | 171 | 0.040 |
Why?
|
| Ocular Physiological Phenomena | 1 | 1977 | 11 | 0.040 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2018 | 66 | 0.030 |
Why?
|
| Nonlinear Dynamics | 2 | 2010 | 74 | 0.030 |
Why?
|
| Multimodal Imaging | 1 | 2017 | 115 | 0.030 |
Why?
|
| Videotape Recording | 1 | 1997 | 49 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2000 | 2506 | 0.030 |
Why?
|
| Gestational Age | 1 | 1997 | 327 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2018 | 278 | 0.030 |
Why?
|
| Hallucinations | 1 | 1996 | 30 | 0.030 |
Why?
|
| Personality | 1 | 2018 | 139 | 0.030 |
Why?
|
| Arm | 1 | 2017 | 96 | 0.030 |
Why?
|
| Interferon-beta | 1 | 1996 | 126 | 0.030 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2017 | 146 | 0.030 |
Why?
|
| Levodopa | 1 | 2015 | 38 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2006 | 3505 | 0.030 |
Why?
|
| Biomarkers | 2 | 2018 | 1847 | 0.030 |
Why?
|
| Dementia | 1 | 1996 | 203 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 4073 | 0.030 |
Why?
|
| Mathematics | 2 | 1991 | 191 | 0.030 |
Why?
|
| Reference Values | 4 | 1994 | 660 | 0.030 |
Why?
|
| Aging | 1 | 1998 | 741 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2000 | 3776 | 0.030 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2012 | 26 | 0.020 |
Why?
|
| Brain Injuries | 1 | 1994 | 169 | 0.020 |
Why?
|
| Optic Neuritis | 1 | 1991 | 10 | 0.020 |
Why?
|
| Methods | 1 | 1991 | 149 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2012 | 250 | 0.020 |
Why?
|
| United States | 1 | 2003 | 7360 | 0.020 |
Why?
|
| Preoperative Period | 1 | 2010 | 98 | 0.020 |
Why?
|
| Dura Mater | 1 | 2010 | 47 | 0.020 |
Why?
|
| Median Nerve | 1 | 1989 | 12 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 902 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 1991 | 488 | 0.020 |
Why?
|
| Regression Analysis | 2 | 2003 | 594 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2010 | 311 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 376 | 0.020 |
Why?
|
| Electric Conductivity | 2 | 2005 | 145 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2017 | 4474 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2020 | 9693 | 0.020 |
Why?
|
| Insulin | 2 | 1992 | 1168 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2003 | 1761 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 1990 | 240 | 0.020 |
Why?
|
| Cognition | 1 | 1992 | 603 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 5708 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1992 | 574 | 0.020 |
Why?
|
| Sugar Alcohol Dehydrogenases | 1 | 1986 | 2 | 0.020 |
Why?
|
| Imidazolidines | 1 | 1986 | 3 | 0.020 |
Why?
|
| Aldehyde Reductase | 1 | 1986 | 9 | 0.020 |
Why?
|
| Endarterectomy | 1 | 1986 | 23 | 0.020 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 1986 | 24 | 0.020 |
Why?
|
| Diabetic Neuropathies | 1 | 1986 | 41 | 0.020 |
Why?
|
| Imidazoles | 1 | 1986 | 141 | 0.010 |
Why?
|
| Carotid Artery Diseases | 1 | 1986 | 101 | 0.010 |
Why?
|
| Malingering | 1 | 1985 | 5 | 0.010 |
Why?
|
| Saccades | 1 | 2004 | 69 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2004 | 168 | 0.010 |
Why?
|
| Finite Element Analysis | 1 | 2003 | 78 | 0.010 |
Why?
|
| Amblyopia | 1 | 1983 | 9 | 0.010 |
Why?
|
| Depth Perception | 1 | 1983 | 19 | 0.010 |
Why?
|
| Strabismus | 1 | 1983 | 11 | 0.010 |
Why?
|
| Pupil | 1 | 1983 | 20 | 0.010 |
Why?
|
| Optic Disk | 1 | 1983 | 15 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 1986 | 1150 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 305 | 0.010 |
Why?
|
| Glaucoma, Open-Angle | 1 | 1983 | 21 | 0.010 |
Why?
|
| Child Behavior | 1 | 1983 | 47 | 0.010 |
Why?
|
| Intraoperative Period | 2 | 1997 | 93 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2004 | 468 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2012 | 2453 | 0.010 |
Why?
|
| Glucose Clamp Technique | 2 | 1992 | 42 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2004 | 387 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 1593 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2006 | 2979 | 0.010 |
Why?
|
| Vision, Binocular | 1 | 1997 | 21 | 0.010 |
Why?
|
| Vision, Ocular | 1 | 1977 | 71 | 0.010 |
Why?
|
| Blood Glucose | 2 | 1992 | 855 | 0.010 |
Why?
|
| Child Development | 1 | 1997 | 168 | 0.010 |
Why?
|
| Form Perception | 1 | 1976 | 37 | 0.010 |
Why?
|
| Syndrome | 1 | 1996 | 449 | 0.010 |
Why?
|
| Infant, Premature | 1 | 1997 | 298 | 0.010 |
Why?
|
| Age of Onset | 1 | 1994 | 332 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1994 | 144 | 0.010 |
Why?
|
| Epinephrine | 1 | 1992 | 89 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 1996 | 1900 | 0.010 |
Why?
|
| Glucagon | 1 | 1992 | 113 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1992 | 96 | 0.010 |
Why?
|
| Self Care | 1 | 1992 | 169 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1992 | 304 | 0.010 |
Why?
|
| Peroneal Nerve | 1 | 1986 | 9 | 0.000 |
Why?
|
| Neural Conduction | 1 | 1986 | 71 | 0.000 |
Why?
|
| Carotid Artery, Internal | 1 | 1986 | 70 | 0.000 |
Why?
|
| Random Allocation | 1 | 1986 | 328 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1996 | 6917 | 0.000 |
Why?
|
| Respiration | 1 | 1986 | 269 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1986 | 1755 | 0.000 |
Why?
|
| Neural Inhibition | 1 | 1977 | 99 | 0.000 |
Why?
|
| Light | 1 | 1977 | 295 | 0.000 |
Why?
|